American Journal of Respiratory Cell and Molecular Biology 2014-08-01

T cells and lung injury. Impact of rapamycin.

Takeshi Nakajima, Ko-Wei Lin, Jinghong Li, Halvor S McGee, Jennifer M Kwan, David L Perkins, Patricia W Finn

Index: Am. J. Respir. Cell. Mol. Biol. 51(2) , 294-9, (2014)

Full Text: HTML

Abstract

Acute lung injury (ALI) is characterized by pulmonary inflammation and edema. Innate immune cells (e.g., neutrophils and macrophages) are major contributors to inflammation in ALI. Less is known regarding the role of T cells. We examined the effects of rapamycin on inflammation in a LPS-induced murine model of ALI. Rapamycin was administered before and after initiation of injury. Inflammatory parameters, including bronchoalveolar lavage cell counts, T cell surface markers (i.e., cytotoxic T lymphocyte antigen 4 [CTLA4] and fork head-winged helix transcription factor [Foxp3]), T cell activation (CD69), IL-6, and IL-10 were analyzed. Rapamycin significantly decreased inflammatory parameters and decreased Foxp3, CTLA4, and CD69 in CD4(+) T cells. Rapamycin administration before or after the onset of lung injury, as well as systemically or by pulmonary routes, ameliorates inflammation in ALI.